Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -15.15% is in line with its 5-year average of -14.14%, around the middle of its 5-year range (-23.89%–-2.95%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.49% above its 12-month average of -15.23%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -15.15%.
RETURN ON INVESTED CAPITAL (ROIC)
-15.15%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-15.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-14.89%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-14.14%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+0.49%
CURRENT VS 3Y AVG
-1.72%
CURRENT VS 5Y AVG
-7.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 610 covered companies
CURRENT VS SECTOR MEDIAN
+54.93%
vs the sector median at left
Janux Therapeutics, Inc.
Market Cap
$998.42M
Return on Invested Capital (ROIC)
-15.15%
TTM Avg
-15.23%
3Y Avg
-14.89%
5Y Avg
-14.14%
Market Cap
$997.34M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.01B
Return on Invested Capital (ROIC)
-53.36%
TTM Avg
-19.72%
3Y Avg
-15.42%
5Y Avg
-34.93%
Market Cap
$990.12M
Return on Invested Capital (ROIC)
-16.54%
TTM Avg
-24.45%
3Y Avg
-23.43%
5Y Avg
-23.43%
Market Cap
$982.03M
Return on Invested Capital (ROIC)
-28.14%
TTM Avg
-132.46%
3Y Avg
-76.17%
5Y Avg
-76.17%
Market Cap
$985.37M
Return on Invested Capital (ROIC)
52.81%
TTM Avg
-75.45%
3Y Avg
-63.24%
5Y Avg
-50.31%
Market Cap
$1.02B
Return on Invested Capital (ROIC)
20.01%
TTM Avg
1.42%
3Y Avg
2.77%
5Y Avg
3.34%
Market Cap
$1.04B
Return on Invested Capital (ROIC)
-68.64%
TTM Avg
-46.08%
3Y Avg
-28.67%
5Y Avg
-26.80%
Market Cap
$1.02B
Return on Invested Capital (ROIC)
0.86%
TTM Avg
2.66%
3Y Avg
2.26%
5Y Avg
2.26%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Janux Therapeutics, Inc. (JANX) | $998.42M | -15.15% | -15.23% | -14.89% | -14.14% |
| Latigo Biotherapeutics Inc. (LTGO)vs › | $997.34M | N/A | N/A | N/A | N/A |
| Immatics N.V. (IMTX)vs › | $1.01B | -53.36% | -19.72% | -15.42% | -34.93% |
| Aktis Oncology, Inc. (AKTS)vs › | $990.12M | -16.54% | -24.45% | -23.43% | -23.43% |
| LB Pharmaceuticals Inc Common Stock (LBRX)vs › | $982.03M | -28.14% | -132.46% | -76.17% | -76.17% |
| MeiraGTx Holdings plc (MGTX)vs › | $985.37M | 52.81% | -75.45% | -63.24% | -50.31% |
| Integra LifeSciences Holdings Corporation (IART)vs › | $1.02B | 20.01% | 1.42% | 2.77% | 3.34% |
| Cullinan Therapeutics, Inc. (CGEM)vs › | $1.04B | -68.64% | -46.08% | -28.67% | -26.80% |
| Lumexa Imaging Holdings, Inc. Common Stock (LMRI)vs › | $1.02B | 0.86% | 2.66% | 2.26% | 2.26% |
| Castle Biosciences, Inc. (CSTL)vs › | $1.05B | -6.33% | -3.44% | -10.34% | -8.68% |
ROIC
-15.2%
ROE
-11.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -15.15% |
| 2026-03-31 | -16.20% |
| 2025-12-31 | -16.01% |
| 2025-09-30 | -14.44% |
| 2025-06-30 | -14.33% |
| 2025-03-31 | -10.99% |
| 2024-12-31 | -9.47% |
| 2024-09-30 | -12.68% |
| 2024-06-30 | -9.70% |
| 2024-03-31 | -10.74% |
| 2023-12-31 | -19.87% |
| 2023-09-30 | -20.17% |
| 2023-06-30 | -23.89% |
| 2023-03-31 | -21.92% |
| 2022-12-31 | -19.31% |
| 2022-09-30 | -17.34% |
| 2022-06-30 | -14.82% |
| 2022-03-31 | -12.41% |
| 2021-12-31 | -8.97% |
| 2021-09-30 | -5.57% |
| 2021-06-30 | -2.95% |
| 2021-03-31 | -9.71% |
| 2020-12-31 | -37.15% |
